Blood cancer mystery: scientists hunt for clues to treatment success

NCT ID NCT05440838

Recruiting now Knowledge-focused Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for adults with polycythemia vera, essential thrombocythemia, or pre-myelofibrosis who are starting their first treatment. Researchers want to find out why some patients respond well to standard drugs while others do not. They will look at genetic and immune system factors to help doctors choose the best treatment from the start.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired polycythemia vera cellular phase chronic idiopathic myelofibrosis essential thrombocythemia Myeloproliferative Disorders myeloproliferative neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYELOPROLIFERATIVE NEOPLASM

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Chu Angers
RECRUITING

Angers, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Brest
RECRUITING

Brest, 29606, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Nantes
RECRUITING

Nantes, 44093, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Poitiers
RECRUITING

Poitiers, 86021, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Rennes
RECRUITING

Rennes, 35033, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Tours
RECRUITING

Tours, 37044, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.